(function(){var loadHandler=window['sl_{234E3818-5100-4EEE-8191-9D688D9A81FF}'];loadHandler&&loadHandler(18, '<div id="spr0_993b081"><div id="spr1_993b081" class="kern slide"><img id="img9_993b081" src="data/img0.png" width="720px" height="405px" alt="" style="left:0px;top:0px;"/></div><div id="spr2_993b081" class="kern slide"><div id="svg0_993b081" style="left:-0.693px;top:-5.182px;"><svg width="31" height="415" viewBox="0 0 31 415"><path fill="#c00000" fill-opacity="0.8" d="M0,0 h30.345 v414.682 h-30.345 Z"/></svg></div><div id="spr3_993b081" style="left:29.652px;top:418.391px;"><div style="width:0px;"><span id="txt0_993b081" data-width="654.319336" style="left:7.2px;top:4.513px;">Red blood cell compatibility testing consists of typing for ABO and Rh(D) antigens,</span></div><div style="width:0px;"><span id="txt1_993b081" data-width="664.338867" style="left:7.2px;top:26.113px;">screening the plasma for non-ABO antibodies, and crossmatching prospective RBC</span></div><div style="width:0px;"><span id="txt2_993b081" data-width="631.371094" style="left:7.2px;top:47.713px;">units. Group O, A, and B persons have naturally occurring strong plasma anti-A</span></div><div style="width:0px;"><span id="txt3_993b081" data-width="652.350586" style="left:7.2px;top:69.313px;">and/or anti-B to the antigens they lack, and RBC units must be ABO compatible to</span></div><div style="width:0px;"><span id="txt4_993b081" data-width="648.307617" style="left:7.2px;top:90.913px;">avoid hemolytic transfusion reactions. D-negative persons can easily make anti-D</span></div><div style="width:0px;"><span id="txt5_993b081" data-width="663.363281" style="left:7.2px;top:112.513px;">when exposed to D-positive red blood cells and should normally receive D-negative</span></div><div style="width:0px;"><span id="txt6_993b081" data-width="659.302734" style="left:7.2px;top:134.113px;">red blood cells. This is especially important for girls and young women to avoid risk</span></div><div style="width:0px;"><span id="txt7_993b081" data-width="643.341797" style="left:7.2px;top:155.713px;">of hemolytic disease of the newborn in future D-positive fetuses. One to 2% of all</span></div><div style="width:0px;"><span id="txt8_993b081" data-width="604.335938" style="left:7.2px;top:177.313px;">patients, and 5 to 20% of multi-transfused patients have non-ABO hemolytic</span></div><div style="width:0px;"><span id="txt9_993b081" data-width="628.426758" style="left:7.2px;top:198.913px;">alloantibodies to Rh and other blood group antigens. These antibodies must be</span></div><div style="width:0px;"><span id="txt10_993b081" data-width="645.407227" style="left:7.2px;top:220.513px;">identified so that RBC units negative for the target antigens can be given to avoid</span></div><div style="width:0px;"><span id="txt11_993b081" data-width="607.306641" style="left:7.2px;top:242.113px;">hemolysis. After these “type and screen” tests, donor red blood cell units are</span></div><div style="width:0px;"><span id="txt12_993b081" data-width="614.285156" style="left:7.2px;top:263.713px;">crossmatched for the patient, either by computer confirmation or, if significant</span></div><div style="width:0px;"><span id="txt13_993b081" data-width="642.331055" style="left:7.2px;top:285.313px;">antibodies are present, by serological crossmatching of plasma versus donor red</span></div><div style="width:0px;"><span id="txt14_993b081" data-width="636.328125" style="left:7.2px;top:306.913px;">blood cells. Compatibility testing routinely takes 45 to 60 minutes or longer if red</span></div><div style="width:0px;"><span id="txt15_993b081" data-width="649.775391" style="left:7.2px;top:328.513px;">blood cells alloantibodies, warm (IgG), or cold (IgM) autoantibodies are present. If</span></div><div style="width:0px;"><span id="txt16_993b081" data-width="626.317383" style="left:7.2px;top:350.113px;">red blood cells must be given emergently before testing is completed, uncross-</span></div><div style="width:0px;"><span id="txt17_993b081" data-width="663.372070" style="left:7.2px;top:371.713px;">matched group O red blood cells are the best choice, after weighing the risk of non-</span></div><div style="width:0px;"><span id="txt18_993b081" data-width="614.364258" style="left:7.2px;top:393.313px;">ABO hemolytic red blood cell antibodies. In an emergency, as a guide to help</span></div><div style="width:0px;"><span id="txt19_993b081" data-width="564.257813" style="left:7.2px;top:414.913px;">remember that group O is a “universal donor,” think of the “O” in donor.</span></div></div><div id="spr4_993b081" style="left:29.652px;top:22.5px;"><div style="width:0px;"><span id="txt20_993b081" data-width="256.787109" style="left:217.049px;top:5.122px;">Blood Compatibility</span></div></div><div id="spr5_993b081" style="left:47px;top:238px;"><div style="width:0px;"><span id="txt21_993b081" data-width="148.078125" style="left:46.377px;top:21.332px;">Group O, A, and B</span></div></div><div id="spr6_993b081" style="left:47px;top:238px;"><img id="img0_993b081" src="data/img85.png" width="238" height="65" alt=""/></div><div id="spr7_993b081" style="left:47px;top:238px;"><div style="width:0px;"><span id="txt22_993b081" data-width="148.078125" style="left:46.377px;top:19.521px;">Group O, A, and B</span></div></div><div id="spr8_993b081" style="left:257px;top:238px;"><div style="width:0px;"><span id="txt23_993b081" data-width="157.078125" style="left:41.968px;top:21.332px;">Anti-A and/or anti-B</span></div></div><div id="spr9_993b081" style="left:257px;top:238px;"><img id="img1_993b081" src="data/img86.png" width="238" height="65" alt=""/></div><div id="spr10_993b081" style="left:257px;top:238px;"><div style="width:0px;"><span id="txt24_993b081" data-width="157.078125" style="left:41.968px;top:19.521px;">Anti-A and/or anti-B</span></div></div><div id="spr11_993b081" style="left:467px;top:238px;"><div style="width:0px;"><span id="txt25_993b081" data-width="150.055664" style="left:45.061px;top:11.612px;">RBC units must be</span></div><div style="width:0px;"><span id="txt26_993b081" data-width="130.060547" style="left:55.061px;top:31.052px;">ABO compatible</span></div></div><div id="spr12_993b081" style="left:467px;top:238px;"><img id="img2_993b081" src="data/img87.png" width="238" height="65" alt=""/></div><div id="spr13_993b081" style="left:467px;top:238px;"><div style="width:0px;"><span id="txt27_993b081" data-width="150.055664" style="left:45.061px;top:9.801px;">RBC units must be</span></div><div style="width:0px;"><span id="txt28_993b081" data-width="130.060547" style="left:55.061px;top:29.241px;">ABO compatible</span></div></div><div id="spr14_993b081" style="left:123px;top:230px;"><div style="width:0px;"><span id="txt29_993b081" data-width="173.083008" style="left:16.657px;top:12.822px;">Especially girls/young</span></div><div style="width:0px;"><span id="txt30_993b081" data-width="58.025391" style="left:74.157px;top:32.262px;">women</span></div></div><div id="spr15_993b081" style="left:123px;top:230px;"><img id="img3_993b081" src="data/img88.png" width="208" height="67" alt=""/></div><div id="spr16_993b081" style="left:123px;top:230px;"><div style="width:0px;"><span id="txt31_993b081" data-width="173.083008" style="left:16.657px;top:11.011px;">Especially girls/young</span></div><div style="width:0px;"><span id="txt32_993b081" data-width="58.025391" style="left:74.157px;top:30.451px;">women</span></div></div><div id="spr17_993b081" style="left:345px;top:237px;"><img id="img4_993b081" src="data/img89.png" width="48" height="54" alt=""/></div><div id="spr18_993b081" style="left:406px;top:230px;"><div style="width:0px;"><span id="txt33_993b081" data-width="165.067383" style="left:20.77px;top:12.822px;">Hemolytic disease in</span></div><div style="width:0px;"><span id="txt34_993b081" data-width="143.059570" style="left:31.77px;top:32.262px;">D-positive fetuses</span></div></div><div id="spr19_993b081" style="left:406px;top:230px;"><img id="img5_993b081" src="data/img88.png" width="208" height="67" alt=""/></div><div id="spr20_993b081" style="left:406px;top:230px;"><div style="width:0px;"><span id="txt35_993b081" data-width="165.067383" style="left:20.77px;top:11.011px;">Hemolytic disease in</span></div><div style="width:0px;"><span id="txt36_993b081" data-width="143.059570" style="left:31.77px;top:30.451px;">D-positive fetuses</span></div></div><div id="svg1_993b081" style="left:126.161px;top:129.829px;"><svg width="498" height="37" viewBox="0 0 498 37"><path fill="#3a889d" d="M0,0 h497.839 v36.688 h-497.839 Z"/></svg></div><div id="spr21_993b081" style="left:126.161px;top:129.829px;"><div style="width:0px;"><span id="txt37_993b081" data-width="59.027344" style="left:220.417px;top:7.365px;">Testing</span></div></div><div id="svg2_993b081" style="left:126.161px;top:166.462px;"><svg width="166" height="49" viewBox="0 0 166 49"><path fill="#632523" d="M0,0 h165.084 v48.831 h-165.084 Z"/></svg></div><div id="spr22_993b081" style="left:126.161px;top:166.462px;"><div style="width:0px;"><span id="txt38_993b081" data-width="126.043945" style="left:19.542px;top:3.729px;">ABO and Rh(D)</span></div><div style="width:0px;"><span id="txt39_993b081" data-width="68.053711" style="left:48.542px;top:25.329px;">antigens</span></div></div><div id="svg3_993b081" style="left:291.245px;top:166.462px;"><svg width="168" height="49" viewBox="0 0 168 49"><path fill="#215968" d="M0,0 h167.67 v48.831 h-167.67 Z"/></svg></div><div id="spr23_993b081" style="left:291.245px;top:166.462px;"><div style="width:0px;"><span id="txt40_993b081" data-width="139.060547" style="left:14.335px;top:3.729px;">Plasma non-ABO</span></div><div style="width:0px;"><span id="txt41_993b081" data-width="82.063477" style="left:42.835px;top:25.329px;">antibodies</span></div></div><div id="svg4_993b081" style="left:458.916px;top:166.462px;"><svg width="166" height="49" viewBox="0 0 166 49"><path fill="#403152" d="M0,0 h165.084 v48.831 h-165.084 Z"/></svg></div><div id="spr24_993b081" style="left:458.916px;top:166.462px;"><div style="width:0px;"><span id="txt42_993b081" data-width="120.041016" style="left:22.542px;top:3.729px;">Crossmatching</span></div><div style="width:0px;"><span id="txt43_993b081" data-width="81.026367" style="left:42.042px;top:25.329px;">RBC units</span></div></div><div id="spr25_993b081" style="left:58px;top:140px;"><div style="width:0px;"><span id="txt44_993b081" data-width="156.084961" style="left:41.321px;top:25.458px;">D-negative persons</span></div></div><div id="spr26_993b081" style="left:58px;top:140px;"><img id="img6_993b081" src="data/img90.png" width="238" height="72" alt=""/></div><div id="spr27_993b081" style="left:58px;top:140px;"><div style="width:0px;"><span id="txt45_993b081" data-width="156.084961" style="left:41.321px;top:23.647px;">D-negative persons</span></div></div><div id="spr28_993b081" style="left:268px;top:140px;"><div style="width:0px;"><span id="txt46_993b081" data-width="50.009766" style="left:94.412px;top:25.458px;">Anti-D</span></div></div><div id="spr29_993b081" style="left:268px;top:140px;"><img id="img7_993b081" src="data/img91.png" width="237" height="71" alt=""/></div><div id="spr30_993b081" style="left:268px;top:140px;"><div style="width:0px;"><span id="txt47_993b081" data-width="50.009766" style="left:94.412px;top:23.647px;">Anti-D</span></div></div><div id="spr31_993b081" style="left:478px;top:140px;"><div style="width:0px;"><span id="txt48_993b081" data-width="143.068359" style="left:48.003px;top:14.658px;">Should receive D-</span></div><div style="width:0px;"><span id="txt49_993b081" data-width="120.058594" style="left:59.503px;top:36.258px;">negative RBCs</span></div></div><div id="spr32_993b081" style="left:478px;top:140px;"><img id="img8_993b081" src="data/img92.png" width="238" height="72" alt=""/></div><div id="spr33_993b081" style="left:478px;top:140px;"><div style="width:0px;"><span id="txt50_993b081" data-width="143.068359" style="left:48.003px;top:12.847px;">Should receive D-</span></div><div style="width:0px;"><span id="txt51_993b081" data-width="120.058594" style="left:59.503px;top:34.447px;">negative RBCs</span></div></div></div></div>');})();